Moreover, an NTRK1 splice variant, TRKA III, and an in-frame deletion mutant (ΔTRKA) were reported in neuroblastoma and acute myeloid leukemia, showing their tumorigenicity [7, 8]. Here, NTRK1 is linked to neuroblastoma.